UCB's Bimzelx and AbbVie's Rinvoq Lead in EU5 Psoriatic Arthritis, Ankylosing Spondylitis, and Non-Radiographic Axial Spondyloarthritis Growth
New insights from Spherix Global Insights reveal strong rheumatologist anticipation for next-generation oral and multi-pathway innovations, including Sotyktu, icotrokinra, and sonelokimab. Exton, PA, Nov. 13, 2025 (GLOBE NEWSWIRE) — The 2025 Market Dynamix™:
(Financial Post, 2025-11-13T22:33:32Z)